Translational Development Acquisition Corp.
TDAC
$10.17
-$0.01-0.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 196.30K | 546.70K | 485.90K | 485.70K | 485.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 196.30K | 546.70K | 485.90K | 485.70K | 485.50K |
| Operating Income | -196.30K | -546.70K | -485.90K | -485.70K | -485.50K |
| Income Before Tax | -70.90K | -546.70K | -485.90K | -485.70K | -485.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.07 | -0.55 | -0.49 | -0.49 | -0.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.90K | -546.70K | -485.90K | -485.70K | -485.50K |
| EBIT | -196.30K | -546.70K | -485.90K | -485.70K | -485.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.14 | -0.12 | -0.12 | -0.12 |
| Normalized Basic EPS | -0.01 | -0.08 | -0.08 | -0.08 | -0.08 |
| EPS Diluted | -0.02 | -0.14 | -0.12 | -0.12 | -0.12 |
| Normalized Diluted EPS | -0.01 | -0.08 | -0.08 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | 17.57M | 16.20M | 16.20M | 16.20M | 16.20M |
| Average Diluted Shares Outstanding | 17.57M | 16.20M | 16.20M | 16.20M | 16.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |